A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...

As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...

尽管AI制药在生物制药领域交易总量中的占比仍维持在五年的平均数4.1%左右， 但其在总资本中的占比在过去两年出现了持续攀升，2024年达9%，2025年升至8.4%。

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...

On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified ...